世界の間葉系幹細胞治療の市場規模は、2024年に8,090万ドルと推定され、2025年から2030年にかけて23.5%のCAGRで成長すると予測されます。間葉系幹細胞 (MSC) 治療市場は、主にその幅広い治療可能性によって推進されています。MSCは、抗炎症、免疫調節、および組織修復の能力を備えているため、整形外科疾患、心血管疾患、自己免疫疾患、創傷治癒など、さまざまな状態の治療に非常に汎用性があります。この多系統化の可能性は、公的機関と民間企業の両方からの強力な研究開発投資を後押ししています。さらに、MSCは骨髄、脂肪組織、臍帯などのさまざまな組織から供給できるため、治療法開発の柔軟性とスケーラビリティが向上します。その安全性と有効性を裏付ける臨床データが蓄積されるにつれて、規制当局の関心と医療提供者の採用が増え続けています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type
1.2.2. Source
1.2.3. Disease Indication
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Broad Therapeutic Potential Across Multiple Diseases
3.3.1.2. Advancements in Cell Culture & Manufacturing Technologies
3.3.2. Market Restraint Analysis
3.3.2.1. Stringent Regulatory Frameworks
3.4. Industry Analysis Tools
3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.2. Porter's Five Forces Analysis
3.4.3. COVID-19 Impact Analysis
Chapter 4. Mesenchymal Stem Cell Therapy Market: Type Business Analysis
4.1. Segment Dashboard
4.2. Global Mesenchymal Stem Cell Therapy Movement Analysis
4.3. Global Mesenchymal Stem Cell Therapy Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Autologous
4.4.1. Global Autologous Market, 2018 - 2030 (USD Million)
4.5. Allogenic
4.5.1. Global Allogenic Market, 2018 - 2030 (USD Million)
Chapter 5. Mesenchymal Stem Cell Therapy Market: Source Business Analysis
5.1. Segment Dashboard
5.2. Global Mesenchymal Stem Cell Therapy Movement Analysis
5.3. Global Mesenchymal Stem Cell Therapy Market Size & Trend Analysis, by Source, 2018 to 2030 (USD Million)
5.4. Bone Marrow
5.4.1. Global Bone Marrow Market, 2018 - 2030 (USD Million)
5.5. Umbilical Cord
5.5.1. Global Umbilical Cord Market, 2018 - 2030 (USD Million)
5.6. Adipose
5.6.1. Global Adipose Market, 2018 - 2030 (USD Million)
5.7. Others Sources
5.7.1. Global Others Sources Market, 2018 - 2030 (USD Million)
Chapter 6. Mesenchymal Stem Cell Therapy Market: Disease Indication Business Analysis
6.1. Segment Dashboard
6.2. Global Mesenchymal Stem Cell Therapy Movement Analysis
6.3. Global Mesenchymal Stem Cell Therapy Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
6.4. Orthopedic and Musculoskeletal Disorders
6.4.1. Global Orthopedic and Musculoskeletal Disorders Market, 2018 - 2030 (USD Million)
6.5. Cardiovascular Diseases
6.5.1. Global Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
6.6. Neurological and CNS Disorders
6.6.1. Global Neurological and CNS Disorders Market, 2018 - 2030 (USD Million)
6.7. Hematological / Immune Disorders
6.7.1. Global Hematological / Immune Disorders Market, 2018 - 2030 (USD Million)
6.8. Others Indications
6.8.1. Global Others Indications Market, 2018 - 2030 (USD Million)
Chapter 7. Mesenchymal Stem Cell Therapy Market: Regional Estimates & Trend Analysis by Type, Source, Disease Indication
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America Mesenchymal stem cell therapy market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. Mesenchymal stem cell therapy market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe Mesenchymal stem cell therapy market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. UK Mesenchymal stem cell therapy market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Germany Mesenchymal stem cell therapy market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Mesenchymal stem cell therapy market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Japan Mesenchymal stem cell therapy market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. South Korea
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. South Korea Mesenchymal stem cell therapy market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Rest of World
7.6.1. Rest of World Mesenchymal Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. MEDIPOST, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. PHARMICELL Co., Ltd
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Antrogen
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. CORESTEMCHEMON Inc.
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. NIPRO Corporation
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. STEMPEUTICS RESEARCH PVT LTD
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. JCR Pharmaceuticals Co Ltd
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Mesoblast, Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Cell Tech Pharmed
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. HOLOSTEM S.r.l.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Takeda Pharmaceutical Company Limited
8.4.11.1. Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 4 Global mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 5 Global mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 6 Global mesenchymal stem cell therapy market, by region, 2018 - 2030 (USD Million)
Table 7 North America mesenchymal stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 8 North America mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 9 North America mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 10 North America mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 11 U.S. mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 12 U.S. mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 13 U.S. mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 14 Europe mesenchymal stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 15 Europe mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 16 Europe mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 17 Europe mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 18 UK mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 19 UK mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 20 UK mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 21 Germany mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 22 Germany mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 23 Germany mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 24 Asia Pacific mesenchymal stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 25 Asia Pacific mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 26 Asia Pacific mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 27 Asia Pacific mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 28 Japan mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 29 Japan mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 30 Japan mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 31 South Korea mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 32 South Korea mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 33 South Korea mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 34 Rest of World mesenchymal stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 35 Rest of World mesenchymal stem cell therapy market, by type, 2018 - 2030 (USD Million)
Table 36 Rest of World mesenchymal stem cell therapy market, by source, 2018 - 2030 (USD Million)
Table 37 Rest of World mesenchymal stem cell therapy market, by disease indication, 2018 - 2030 (USD Million)
Table 38 Participant's overview
Table 39 Financial performance
Table 40 Key companies undergoing expansions
Table 41 Key companies undergoing acquisitions
Table 42 Key companies undergoing collaborations
Table 43 Key companies launching new products
Table 44 Key companies undertaking other strategies
List of Figures
Fig. 1 Mesenchymal stem cell therapy market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 Related/ancillary market outlook
Fig. 14 Genomics - Industry value chain analysis
Fig. 15 Mesenchymal stem cell therapy market driver analysis
Fig. 16 Mesenchymal stem cell therapy market restraint analysis
Fig. 17 Mesenchymal stem cell therapy market: Porter's analysis
Fig. 18 Mesenchymal stem cell therapy market: Type outlook and key takeaways
Fig. 19 Mesenchymal stem cell therapy market: Type market share analysis, 2023 - 2030
Fig. 20 Global mesenchymal stem cell therapy by autologous market, 2018 - 2030 (USD Million)
Fig. 21 Global mesenchymal stem cell therapy by allogenic market, 2018 - 2030 (USD Million)
Fig. 22 Mesenchymal stem cell therapy market: Source outlook and key takeaways
Fig. 23 Mesenchymal stem cell therapy market: Source market share analysis, 2023 - 2030
Fig. 24 Global mesenchymal stem cell therapy by umbilical cord market, 2018 - 2030 (USD Million)
Fig. 25 Global mesenchymal stem cell therapy by adipose market, 2018 - 2030 (USD Million)
Fig. 26 Global mesenchymal stem cell therapy by other sources market, 2018 - 2030 (USD Million)
Fig. 27 Mesenchymal stem cell therapy market: Disease indication outlook and key takeaways
Fig. 28 Mesenchymal stem cell therapy market: Disease indication market share analysis, 2023 - 2030
Fig. 29 Global mesenchymal stem cell therapy by orthopedic and musculoskeletal disorders market, 2018 - 2030 (USD Million)
Fig. 30 Global mesenchymal stem cell therapy by cardiovascular diseases market, 2018 - 2030 (USD Million)
Fig. 31 Global mesenchymal stem cell therapy by neurological and CNS disorders market, 2018 - 2030 (USD Million)
Fig. 32 Global mesenchymal stem cell therapy by hematological / immune disorders market, 2018 - 2030 (USD Million)
Fig. 33 Global mesenchymal stem cell therapy by other indications market, 2018 - 2030 (USD Million)
Fig. 34 Regional marketplace: Key takeaways
Fig. 35 North America mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 U.S. key country dynamics
Fig. 37 U.S. mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Europe mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 UK key country dynamics
Fig. 40 UK mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Germany key country dynamics
Fig. 42 Germany mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Asia-Pacific mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Japan key country dynamics
Fig. 45 Japan mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 South Korea key country dynamics
Fig. 47 South Korea mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Rest of World mesenchymal stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Key company categorization
Fig. 50 Company market positioning
Fig. 51 Market participant categorization
Fig. 52 Strategy framework
